A retrospective study to evaluate the time burden associated with outpatient red blood transfusions indicated for anemia due to concomitantly administered chemotherapy in cancer pa...

od Shreay, Sanatan, Desrosiers, Marie-Pierre, Corey-Lisle, Patricia, Payne, Krista
Wydane 2012

Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database

od Boursier, Jérôme, Shreay, Sanatan, Fabron, Cecile, Torreton, Elodie, Fraysse, Jeremy
Wydane w EClinicalMedicine (2020)

Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain

od Romero-Gomez, Manuel, Kachru, Nandita, Zamorano, Meritxell Ascanio, Darba, Josep, Shreay, Sanatan
Wydane w Medicine (Baltimore) (2020)

Erythropoiesis-Stimulating Agent (ESA) Practice Patterns in Patients With Chemotherapy-Induced Anemia (CIA) Treated at Hospital Oncology Clinics

od Reitan, John F., van Breda, Arletta, Shreay, Sanatan, Corey-Lisle, Patricia K., Cong, Ze
Wydane 2013

Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimula...

od Cappell, Katherine A, Shreay, Sanatan, Cao, Zhun, Varker, Helen V, Paoli, Carly J, Gitlin, Matthew
Wydane 2014

Efficiency of U.S. Dialysis Centers: An Updated Examination of Facility Characteristics That Influence Production of Dialysis Treatments

od Shreay, Sanatan, Ma, Martin, McCluskey, Jill, Mittelhammer, Ron C, Gitlin, Matthew, Stephens, J Mark
Wydane w Health Serv Res (2014)

Staff Time and Motion Assessment for Administration of Erythropoiesis-Stimulating Agents: A Two-Phase Pilot Study in Clinical Oncology Practices

od Reitan, John F., van Breda, Arletta, Corey-Lisle, Patricia K., Shreay, Sanatan, Cong, Ze, Legg, Jason
Wydane 2013

Clinical Factors and the Decision to Transfuse Chronic Dialysis Patients

od Whitman, Cynthia B., Shreay, Sanatan, Gitlin, Matthew, van Oijen, Martijn G. H., Spiegel, Brennan M. R.
Wydane 2013

Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricita...

od Gathe, Joseph, Arribas, Jose R., Van Lunzen, Jan, Garner, Will, Speck, Rebecca M., Bender, Randall, Shreay, Sanatan, Nguyen, Thai
Wydane w Patient (2015)

Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial

od Ghia, Paolo, Coutre, Steven E., Cheson, Bruce D., Barrientos, Jacqueline C., Hillmen, Peter, Pettitt, Andrew R., Zelenetz, Andrew D., Shreay, Sanatan, Hallek, Michael, Furman, Richard R.
Wydane w Haematologica (2020)

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial

od Montillo, Marco, Illés, Árpád, Robak, Tadeusz, Pristupa, Alexander S., Wach, Malgorzata, Egyed, Miklós, Delgado, Julio, Jurczak, Wojciech, Morschhauser, Franck, Schuh, Anna, Eradat, Herbert, Shreay, Sanatan, Barrientos, Jacqueline C., Zelenetz, Andrew D.
Wydane w Health Qual Life Outcomes (2019)

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

od Salles, Gilles, Schuster, Stephen J., de Vos, Sven, Wagner-Johnston, Nina D., Viardot, Andreas, Blum, Kristie A., Flowers, Christopher R., Jurczak, Wojciech J., Flinn, Ian W., Kahl, Brad S., Martin, Peter, Kim, Yeonhee, Shreay, Sanatan, Will, Matthias, Sorensen, Bess, Breuleux, Madlaina, Zinzani, Pier Luigi, Gopal, Ajay K.
Wydane w Haematologica (2017)